Skip to Main Content

Paper Details

A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis.
EMBO Mol Med
11
2022
HSP90, METPlatform, brain, brain metastases, brain metastasis, human, metastatic disease, mouse, organotypic cultures
Author NameAffiliation
Tobias WeissClinical Neuroscience Center, University Hospital Zurich and University of Zurich
Osvaldo Gra??a
Michael D TaylorDevelopmental and Stem Cell Biology Program and The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children
Michael D TaylorDevelopmental and Stem Cell Biology Program and The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children
Fergus J CouchMayo Clinic
Fergus J CouchMayo Clinic
Michael WellerClinical Neuroscience Center, University Hospital Zurich and University of Zurich
  • 1 - 7

Datasets

Release 1.2